Institutional investors purchased a net $3.8 million shares of CVM during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 8.59% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRIGATE VENTURES LP Bought 1.0 Million shares of CEL-SCI Corp
NATIONAL ASSET MANAGEMENT, INC. Bought 99.0 Thousand shares of CEL-SCI Corp
BLACKROCK FUND ADVISORS Bought 88.9 Thousand shares of CEL-SCI Corp